On June 22, the PMDA held the “PMDA-ATC Good Registration Management (GRM) Webinar 2022 for CDSCO”. This webinar was designed for staff members of the Central Drugs Standard Control Organization (CDSCO), India, who are engaged in review of pharmaceuticals. A total of 40 CDSCO regulators was participated in it.
The PMDA and CDSCO exchanged their views regarding the importance of pre-application consultation as well as the acceptance of overseas clinical trials in line with post-marketing requirements.
The PMDA continues to promote collaboration with CDSCO through training seminars and other activities etc.
See attached program [23KB]
Back
Back
-
Regulations & Services of PMDAInformation about Approved Products in JapanSafety InformationAdvanced Efforts
-
Information for approved products in JapanSafety information
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnosticsInformation for approved products in JapanRegulatory science
-
Regulations and services of PMDAInformation for approved products in JapanProcedures in JapanAdvanced efforts
Back
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Regulations and Services of PMDAInformation for apporoved products in JapanSafety informationProcedures in Japan
-
Reviews and Related ServicesRegulatory ProceduresPost-marketing Safety Measures
-
Reviews and Related ServicesPost-marketing Safety Measures
- Home
- Events and Symposia
- Report of the PMDA-ATC Good Registration Management (GRM) Webinar 2022 for CDSCO
Events and Symposia